Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells  by Desmet, Emily A. et al.
Virology 400 (2010) 224–232
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roMixed Lineage Kinase 3 deﬁciency delays viral clearance in the lung and is associated
with diminished inﬂuenza-induced cytopathic effect in infected cells
Emily A. Desmet a, Joseph A. Hollenbaugh a, Patricia J. Sime a,b,d, Terry W. Wright a,c, David J. Topham a,e,
Andrea J. Sant a,e, Toru Takimoto a, Stephen Dewhurst a,d, Sanjay B. Maggirwar a,⁎
a Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
b Department of Medicine, Environmental Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
c Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
d Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
e Center for Vaccine Biology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA⁎ Corresponding author. Department of Microbiology
Rochester Medical Center, Box 672, 601 Elmwood Aven
Fax: +1 585 473 9573.
E-mail addresses: Emily_desmet@urmc.rochester.ed
joseph_hollenbaugh@urmc.rochester.edu (J.A. Hollenba
patricia_sime@urmc.rochester.edu (P.J. Sime), terry_wr
(T.W. Wright), david_topham@urmc.rochester.edu (D.J.
andrea_sant@urmc.rochester.edu (A.J. Sant), toru_takim
(T. Takimoto), Stephen_dewhurst@urmc.rochester.edu
sanjay_maggirwar@urmc.rochester.edu (S.B. Maggirwar
0042-6822/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.virol.2010.02.001a b s t r a c ta r t i c l e i n f oArticle history:
Received 30 October 2009
Returned to author for revision
30 November 2009
Accepted 1 February 2010
Available online 25 February 2010
Keywords:




T cellInﬂuenza virus leads to acute respiratory disease resulting in seasonal epidemics and periodic pandemics.
Little is known about the signaling events that regulate host defense to inﬂuenza. One particular pathway,
the c-Jun amino-terminal kinase (JNK) cascade is activated following inﬂuenza infection and blocking JNK
leads to enhanced viral replication. We hypothesize that Mixed Lineage Kinase 3 (MLK3), an upstream
regulator of JNK, is involved in the host response to inﬂuenza. To test this, wild-type and MLK3−/− mice
were infected with pathogenic strain of inﬂuenza A virus, A/PR/8/34 (PR8). Although, cellular and humoral
immune responses were similar between wild-type and MLK3−/− hosts, the viral load in the lungs was
comparatively higher in MLK3−/− mice at day 8 post-infection. Consistent with this, MLK3−/− murine
lung ﬁbroblast and epithelial cells had prolonged survival and increased virion production following
infection compared to wild-type. These ﬁndings support a role for MLK3 in viral production during inﬂuenza
infection.and Immunology, University of
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Inﬂuenza A virus, a member of the orthomyxoviridae, leads to
acute respiratory disease resulting in seasonal epidemics and periodic
pandemics. Per year, an estimated 200,000–500,000 people world-
wide die from seasonal inﬂuenza infection and, in 2007, the economic
burden was projected to exceed $87 billion annually (Molinari et al.,
2007). Inﬂuenza infection leads to the onset of an immune response
characterized by an increase in the level of chemokine and cytokine
production,migration of immune inﬁltrates to the site of infection and
apoptosis of infected cells (Brydon et al., 2005). This inﬂammatory
and apoptotic response is important both in containing virus infection
and also in the outcome of that infection, since it is directly related tothe morbidity and mortality in hosts infected with inﬂuenza (Kash et
al., 2006; Korteweg and Gu, 2008).
Little is known about the signaling pathways that regulate host
defense to inﬂuenza virus infection. A potential target for investiga-
tion are the mitogen activated protein kinase (MAPK) pathways and
their upstream regulators. Inﬂuenza A virus infection is known to
activate MAPK pathways in the infected cell, including the Jun-N-
terminal kinase (JNK) cascade, which is involved in the antiviral,
inﬂammatory and apoptotic responses to inﬂuenza (Gallo and
Johnson, 2002; Ludwig et al., 2006). Previous studies suggest that
blockade of JNK activation leads to increased inﬂuenza virus titers in
vitro, decreased AP-1 transcriptional activity, defective Th cell
differentiation and increased cell survival (Dong et al., 2000; Ludwig
et al., 2001; Sabapathy et al., 2001). Treatment of human bronchial
epithelial cells (BEC) with CEP1347, a pharmacologic inhibitor of
MAP3K Mixed Lineage Kinase 3 (MLK3), strongly inhibited JNK
activity during in vitro inﬂuenza infection (Kujime et al., 2000). Thus,
we became interested in the role of MLK3 in inﬂuenza infection.
MLK3 is a serine/threonine MAPK kinase kinase (MAP3K) that
targets JNK through the activation of its immediate downstream
targetsMAPK kinase 7 (MKK7) and, to a lesser extent, MKK4 (Handley
et al., 2007b). While JNK is thought to be MLK3's main downstream
target, MLK3 is known to activate p38 and ERK as well (Chadee and
Kyriakis, 2004; Gallo and Johnson, 2002; Hong and Kim, 2007; Tibbles
Fig. 1. Kinetics of weight loss following infection. A) Mice were infected with 400 EID of
virus and weight loss was monitored daily for 14 days. B) Kinetics of production and
clearance of A/PR/8/34 in the lung of MLK3−/− and wild-type mice infected
intransally with 400 EID of virus. On days 2, 5, 8, 10, 12 and 14 post-infection lungs
were harvested and homogenized. Viral titers in the resulting homogenates were
determined by injecting serial dilutions of homogenates into fertilized hen eggs.
Hemagglutination assays were performed on allantoic ﬂuid from these eggs. Bars
indicate mean values from 3 to 8 animals; error bars denote the standard error of the
mean (SEM). Results shown are representative of 3 total experiments that yielded
similar results. *, pb0.05; Mann–Whitney U test.
225E.A. Desmet et al. / Virology 400 (2010) 224–232et al., 1996; Xu et al., 2001). Critical to MLK3 activation are Ras
GTPases, which are in turn activated in response to a broad range of
extracellular stress stimuli including chemokines and pathogen-
associated molecular patterns (PAMP), both of which are present
during inﬂuenza infection.
A role for the MLK3-JNK cascade in the control of inﬂuenza
infection has also been suggested on the basis that CEP1347 blockade
of the MLK3-JNK cascade resulted in reduced RANTES production by
inﬂuenza A virus-infected human BEC cultures (Kujime et al., 2000).
This ﬁnding suggests that MLK3 activation may promote immune cell
inﬁltration and inﬂammation during infection with inﬂuenza. MLK3 is
also known to regulate cell fate in experimental models of other virus
infections, including HIV-1 associated neurologic disease (HAND). For
instance, CEP1347 treatment blocked HIV-1 Tat-induced activation of
MLK3 and its downstream target JNK, resulting in a substantial
reduction in apoptosis in Tat-exposed neurons (Sui et al., 2006).
Similar ﬁndings have been obtained in other well-studied paradigms
of neuronal apoptosis, suggesting that MLK3 may globally regulate
cell survival through the action of downstream effectors such as JNK
(Mota et al., 2001).
To date, few studies have examined the role of MAPK pathways
in virus infection using an animal model system. We therefore em-
ployed MLK3 knockout mice to examine the role of MLK3 in host
defense to inﬂuenza A virus infection. Mice were experimentally
infected with a well-characterized, pathogenic strain of inﬂuenza A
virus, A/PuertoRico/8/34 (PR8). Our results showed that, in the
absence of MLK3, there was increased accumulation of inﬂuenza
virus in the lung. The increased viral load was associated with pro-
longed survival of MLK3−/− lung cells following in vitro infection
with inﬂuenza virus, corresponding with increased virus production,
relative to cells from wild-type mice. In contrast, MLK3−/− and
wild-type mice did not appear to have gross differences in cytokine
and chemokine responses to inﬂuenza, nor in immune cell inﬁl-
tration into the lung. Similarly, the magnitude of virus-speciﬁc cel-
lular and humoral immune responses that was tested was similar in
wild-type and MLK3 deﬁcient mice. These data suggest that MLK3
may regulate the outcome of inﬂuenza virus infection by controlling
the extent and duration of virus replication in lung cells, resulting in
a transient increase in virion production at late time points following
infection.Results
MLK3−/− mice have elevated levels of virus present in the lung
To evaluate the role of MLK3 during inﬂuenza infection, we took
advantage of an in vivo infection model using MLK3−/− mice
backcrossed onto the C57BL/6J strain (Brancho et al., 2005). Previous
studies indicated that these mice are healthy with no apparent
phenotype aside from a slight defect in TNF-stimulated JNK activation
(Brancho et al., 2005). In all of our experiments, C57BL/6J (Jackson
Laboratory) was used for wild-type controls.
We ﬁrst determined the LD50 for PR8 intranasal infection in both
strains of mice. This analysis did not result in signiﬁcant quantitative
differences between MLK3−/− and wild-type mice and the LD50 was
determined to be 505.9 and 482.7egg infectious doses (EID),
respectively. Based on this, we chose to perform subsequent
experiments with 400 EID of PR8, a sublethal dose allowing
characterization through day 14 post-infection. To examine weight
loss and general morbidity following infection with PR8 virus, ten-
week-old wild-type and MLK3−/− mice were infected intranasally
and were monitored daily for 14 days after infection. Weight loss was
comparable between MLK3−/− and wild-type mice (Fig. 1A).
However, during the course of infection, wild-type mice appeared
lethargic with rufﬂed fur, scrunched posture and stiffness. In contrast,MLK3−/− mice were more active and showed reduced signs of
morbidity.
Because heightened morbidity is often associated with increased
viral titers, we next determined the amount of virus present in the
lungs of both groups (Baskin et al., 2009). Lungs from infected mice
were isolated at days 2–14 post-infection and virus titer in lung
homogenates was measured in fertilized hen eggs. Both groups of
mice displayed equivalent viral titers in the lung at day 2 post-
infection. In wild-type mice, there was a progressive decline in the
amount of virus present in the lung over time, reaching undetectable
levels by day 12. In contrast, sustained high viral titers were detected
in the lungs of MLK3−/− mice through day 8 post-infection. Titers
then declined to undetectable levels by day 12 (Fig. 1B). This suggests
that MLK3 ablation resulted in a transient delay in viral clearance in
the lung, but that the MLK3 deﬁcient mice were ultimately able to
clear the infection.
Immune cell inﬁltration following inﬂuenza infection is similar between
wild-type and MLK3−/− mice
Previous work characterizing highly pathogenic strains of inﬂu-
enza virus demonstrates that increased amounts of virus in the lung
often correlate with increased cell inﬁltration to the site of infection
(Conenello and Palese, 2007; Kobasa et al., 2004; Perrone et al., 2008;
Svitek et al., 2008). Therefore, because an elevated viral load was
found in the lungs of MLK3−/− mice, immune cell inﬁltration into
lung tissue was examined by performing H&E staining on sections
prepared from lungs of virus-infected animals isolated at days 0, 6 and
8 post-infection. Early experiments were performed using an
inoculating dose of 400 EID per animal. At this dose, there was very
extensive lung pathology in both wild-type and MLK3−/− animals
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differences between wild-type and MLK3−/− mice, we repeated
these experiments at a lower dose of 60 EID per animal. Blind scoring
of lung sections revealed that there was no signiﬁcant difference in
immune cell inﬁltration into the lung between groups at these time
points (Fig. 2A).
To further characterize lymphocyte inﬁltration, mAb staining and
analysis was performed to enumerate CD4+, CD8+ and CD19+ cells in
bronchial alveolar lavage (BAL) ﬂuid and lung homogenates. Immune
inﬁltrates were analyzed in tissues collected at days 2, 4, 6, 8 and 10
post-infection. These experiments revealed equivalent numbers of
CD4+, CD8+ and CD19+ cells in both lung and BAL samples isolated
fromwild-type andMLK3−/−mice (Fig. 2B). Therefore, there was no
correlation between lung cell inﬁltration and virus burden in the lung
(Cilloniz et al., 2009).
MLK3−/− mice have similar levels of antigen-speciﬁc CD8+ T cells
compared to wild-type mice
To characterize T cell priming and differentiation inMLK3-deﬁcient
mice, virus-speciﬁc CD8+ T cells were quantiﬁed at day 8 after
infection and the total number of epitope-speciﬁc CD8+ T cells in the
lung was determined by tetramer staining. Single cell suspensions
were labeledwith CD4, CD8 andNP366–374 and PA224–233 tetramers and
examined by ﬂow cytometry. Fig. 3 shows that MLK3−/− and wild-
type mice had similar numbers of peptide-speciﬁc CD8+ T cells at dayFig. 2.H&E staining of lung sections from inﬂuenza virus-infectedmice. A) Groups of 5 wild-t
6 and 8 after infection. Lavaged lungs were ﬁxedwith 10% formalin prior to isolation. H&E sta
immune response in WT and MLK3−/−mice intranasally infected with 400 EID of PR8. Bro
after infection. Data points represent pooled cells from 3 to 5 animals per time point. Total ce
the total number of cells recovered from the sample. Results shown are representative of t8 in the lung. To further conﬁrm this ﬁnding, we also performed IFN-γ
ELISPOT analysis on puriﬁed CD8+ (Fig. 3B) and CD4+ (Fig. 3C) T cells
isolated from the spleen and mediastinal lymph node (MLN) of
infected mice at days 4, 6, 8 and 10 after infection. At day 8 after
infection, MLK3−/− mice displayed elevated numbers of IFN-γ
producing CD8+ T cells isolated from the spleen and MLN, and CD4+
T cells isolated from the spleen. IL-2 ELISPOT analysis was similarly
performed on days 6, 8 and 10. These experiments revealed no
signiﬁcant difference between groupswith regard to the number of IL-
2 producing CD4+ T cells speciﬁc for selected immunodominant class I
(CD8) and class II (CD4) restricted epitopes from the PR8 vi-
rus (Supplementary Fig. 1). Collectively, these results suggest that
(i) CD8+ T cells can recognize and respond to antigen presentation in
the absence ofMLK3, (ii) the expansion of the CD8+T cell population is
not signiﬁcantly impaired by MLK3 deﬁciency, (iii) lack of MLK3 does
not result in impaired immune cell trafﬁcking to the lung and to
secondary lymphoid tissue and (iv) CD4+ and CD8+ T cells isolated
from the spleen and MLN of MLK3−/− mice have the capacity to
produce IFN-γ and IL-2.
MLK3−/− and wild-type mice have similar titers of IgG antibody at day
12 in the serum following inﬂuenza virus infection
To further examine the functionality of the T cell response, we next
evaluated the antigen-speciﬁc IgG antibody response in MLK3−/−
mice. It is known that CD4+ T cells contribute to the switch from IgMype (WT) andMLK3−/−mice were infected with 60 EID of PR8 and sacriﬁced at days 0,
ining was performed on tissue sections. Magniﬁcation is ×100. B) Kinetics of the cellular
nchial alveolar lavage (BAL) ﬂuid and lung tissue was collected at days 2, 4, 6, 8 and 10
ll counts were calculated by multiplying the frequency of CD4+, CD8+ or CD19+ cells by
hree separate experiments.
Fig. 3. Proﬁle of CD8+ T cells speciﬁc for immunodominant NP366–374 (NP) and PA224–233 (PA) epitopes at day 8 post-infection in selected tissue compartments. MLK3−/− andwild-
type (WT) mice were intranasally infected with 400 EID of PR8. A) Lungs were isolated at day 8 post-infection and processed and assayed by ﬂow cytometry for the presence of NP
and PA-speciﬁc CD8+ T cells. Data points represent individual mice with 5 mice per group; bars denote mean for the group. Results shown are representative of 3 individual
experiments. ELISPOT analysis of inﬂuenza virus-speciﬁc CD8 (B) and CD4 (C) IFN-γ producing cells. Spleen and mediastinal lymph node (MLN) were isolated at days 4, 6, 8 and 10
after infection. Cells from the spleen (pooled) and MLN (pooled) were puriﬁed using MACS separation. The number of total IFN-γ secreting cells was quantiﬁed using ELISPOT
analysis with peptides for 2 immunodominant epitopes for CD4 and CD8. Depicted is the average number of spots from triplicate wells. Spot forming units is abbreviated as s.f.u.
Results shown are representative of two separate experiments.
Fig. 4. IgG antibody responses in serum obtained from wild-type and MLK3−/−mice.
Tail vein bleeds were performed on both groups at day 12 after intranasal infection with
400 EID of inﬂuenza A virus strain PR8. Titers of PR8-speciﬁc antibody were determined
by ELISA. Lines indicate mean values from 5 animals; error bars denote the standard
error of the mean (SEM).
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response (Lee et al., 2005; Sangster et al., 2003; Wells et al., 1981). To
evaluate this component of the immune response, we examined levels
of the inﬂuenza-speciﬁc IgG antibody in infected mice. Serum was
obtained from MLK3−/− and wild-type mice at day 12 following
experimental infectionwith inﬂuenza. An IgG speciﬁc ELISA assay was
employed to determine inﬂuenza-speciﬁc IgG antibody titers in the
serum. These experiments indicated that both strains of mice
displayed similar titers of IgG present at day 12 (Fig. 4). These results
suggest that MLK3−/− mice are capable of isotype switch from IgM
to IgG during infection with inﬂuenza, further supporting the
conclusion that CD4 T cell responses are intact in MLK3 deﬁcient mice.
MLK3−/− and wild-type mice have similar levels of inﬂammatory
cytokines and chemokines in the lung following inﬂuenza virus infection
In vitro studies using HIV-1 Tat-activated human monocytes have
shown that TNF-α release can be regulated by MLK3 (Sui et al., 2006).
Similar results have also been reported for RANTES production by
228 E.A. Desmet et al. / Virology 400 (2010) 224–232inﬂuenza virus-infected human bronchial epithelial cells (Kujime et
al., 2000). Additionally, downstream targets of MLK3, MKK7 and JNK,
have been implicated in Th cell differentiation during neutral
polarizing conditions (Dong et al., 2000). In order to evaluate the
role of MLK3 in cytokine and chemokine production during inﬂuenza
infection in vivo, we examined the levels of MCP-1, IP-10, TNF-α,
RANTES, IL-4 and IFN-γ in the lung. ELISA assays performed on whole
lung homogenates from wild-type and MLK3−/−mice revealed that
the overall production of these cytokines or chemokines in response
to PR8 infection was similar in both strains of mice (Fig. 5). Therefore,
among the cytokines and chemokines examined in this study, there
appears to be no signiﬁcant or consistent defects in the absence of
MLK3.
MLK3−/− murine lung cells have prolonged viability following
inﬂuenza virus infection and release greater levels of virus progeny,
compared to wild-type cells
Evidence in the literature suggests a pro-apoptotic role for the
Cdc42–MLK3–MKK7–JNK cascade (Hong and Kim, 2007; Kim et al.,
2004; Zhao and Hoffmann, 2006). We therefore hypothesized that the
increased level of virus present in the lungs of MLK3−/−mice might
be a result of increased survival of infected cells. To test this idea, we
examined cellular viability following infection with inﬂuenza virus in
both murine lung ﬁbroblasts (MLF) and alveolar epithelial cells (AEC)
isolated from MLK3−/− and wild-type mice. First, virus-inducedFig. 5. Levels of inﬂammatory cytokines and chemokines in lungs from inﬂuenza virus-infect
and lungs were isolated from wild-type (WT) and MLK3−/−mice at various time points af
lung homogenates. Bars indicate mean values from 3 to 5 animals; error bars denote the stcytopathic effects (CPE) such as cell rounding, shrinking and
detachment from the plate was evaluated in cells infected with the
inﬂuenza A virus strain PR8 for 12–72 h. MLFs from the MLK3−/−
host demonstrated signiﬁcantly reduced CPE beginning at 24 h post-
infection relative to MLFs isolated from wild-type animals (Fig. 6A).
Similar to MLFs, MLK3−/− AECs demonstrated reduced CPE during
infection with inﬂuenza (data not shown). We next quantiﬁed the
survival of infectedMLF and AECs by trypan blue exclusion. Consistent
with the CPE data, signiﬁcantly more MLK3−/−MLFs and AECs were
viable at 24 and 48 h post-infection when compared with the wild-
type cells (Fig. 6B). These results suggest the involvement of MLK3 in
cellular resistance to inﬂuenza infection.
Since cytopathic effect is an outcome of virus infection, one
possible explanation for these ﬁndings is that MLK3−/− cells might
be more resistant to inﬂuenza virus infection relative to cells from
wild-type mice. To determine if this was the case, immunoﬂuores-
cence staining of cells infected with various doses of PR8 was
performed. MLF and AECs from both wild-type and MLK3−/− hosts
exhibited similar levels of virus infection, as assessed by immunos-
taining for viral nucleoprotein and cell nuclei (data not shown).
Finally, we examined whether prolonged survival of inﬂuenza
virus-infected MLK3−/− cells resulted in increased viral production.
To evaluate this, supernatants from infected MLF and AECs were
collected at 12, 24, 48 and 72 h following infection and the level of
virus in the supernatant was titrated on MDCK cells. Results from this
experiment showed that both MLK3−/− MLF and AECs exhibiteded wild-type and MLK3−/−mice. Mice were infected with inﬂuenza A virus strain PR8
ter infection. ELISA for the indicated cytokines and chemokines was then performed on
andard error of the mean (SEM).
Fig. 6.MLK3−/− cells are resistant to inﬂuenza virus-induced cell killing, and produce larger amounts of progeny virions when compared to cells from wild-type mice. Wild-type
(WT) and MLK3−/−MLF or AEC were infected with inﬂuenza A virus strain PR8 (MOI=3) and then analyzed at various time points. A) Virus-infected MLFs (WT and MLK3−/−)
were analyzed at the indicated time points by light microscopy. Results are representative of 3 individual experiments. Magniﬁcation is ×100. B) Virus-infected MLF and AECs (WT
and MLK3−/−) were subjected to trypan blue staining at the indicated time points to determine viability. Bars indicate mean values from three replicates; error bars denote the
standard error of themean (SEM). *, pb0.05; Mann–Whitney test. C) Progeny virion release in supernatants from virus-infected MLF and AECs (WT andMLK3−/−) was determined
at the indicated time points, by TCID50 assay in MDCK cells. Bars indicate mean values from two replicates. Results are representative of at least 2 identical experiments.
229E.A. Desmet et al. / Virology 400 (2010) 224–232prolonged virus production, relative to wild-type cells (Fig. 6C).
Collectively, these data suggest that loss of MLK3 leads to sustained
survival of infected target cells allowing for extended shedding of
virus.
Discussion
In this study, we suggest a role for MLK3 in regulating the outcome
of inﬂuenza infection in vivo. Our study revealed that the genetic
ablation of MLK3 was associated with elevated virus production at
late time points following infection in vivo. Our data also showed that
cultured lung cells from MLK3−/− mice were resistant to inﬂuenza
virus-mediated cell killing, and were able to sustain release of
progeny virions for an extended time period, relative to lung cells
from wild-type mice. These in vitro ﬁndings suggest that during the
course of infection infected cells in the MLK3−/−mice will continue
to produce virus progeny for longer periods of time leading to more
virions produced per infected cell. Over time, in the absence of MLK3,
this will lead to a greater accumulation and spread of virus in the lung.
Histological and ﬂow analyses suggest that MLK3 is not required
for proliferation of immune cells or the inﬁltration of these cells into
the lung during infection with inﬂuenza. Previous reports on MLK3's
role in cell proliferation and migration have been contradictory
(Brancho et al., 2005; Chadee and Kyriakis, 2004). MLK3 was
suggested to be essential for the proliferation of serum stimulated
ﬁbroblasts by Chadee and Kyriakis (2004), but studies by Brancho et
al. on the proliferation and migration of MEFs from MLK3−/− mice
suggested that MLK has no role in cell proliferation or migration
(Brancho et al., 2005). Overall, our results are consistent with those of
Brancho et al., but not those of Chadee and Kyriakis, suggesting that
MLK3 does not impact either of these processes (Brancho et al., 2005).
MLK3 is known to be expressed in dendritic cells (DC) (Handley et
al., 2007b) and previous studies have suggested that MLKs may beinvolved in DC maturation and activation (Handley et al., 2007a). In
our studies, the levels of antigen-speciﬁc, cytokine secreting CD8+ T
cells were similar in virus-infected MLK3−/−mice versus wild-type
mice, suggesting that the function of DC that prime the adaptive
immune response is not seriously impaired.
MLK3 is also known to regulate the p38 cascade of the MAPK
pathway (Brancho et al., 2005; Chadee and Kyriakis, 2004).
Previously, it was shown that CD4+ and CD8+ T cells isolated from
MKK6 transgenic mice, in which p38 is constitutively active, have
increased IFN-γ production (Merritt et al., 2000; Rincon et al., 1998).
We see a similar trend in CD8+ T cells isolated from MLK3−/−mice
during infection with inﬂuenza. Conze et al. proposed that increased
levels of IFN-γ could augment viral clearance (Conze et al., 2000).
Consistent with this, MLK3−/−mice show clearance in viral titers by
day 10 similar to that detected in the wild-type mice. This ability to
clear virus could be promoted by the boost in IFN-γ production by
antigen-speciﬁc CD8+T cells. However, it is important to note that the
increased IFN-γ production by T cells is not reﬂected in the overall
IFN-γ levels in the total lung.
CEP1347 treatment of human bronchial epithelial cells has been
shown to result in a marked decrease in RANTES release following
H3N2 inﬂuenza virus infection (Kujime et al., 2000). In contrast, our
ﬁndings revealed that RANTES production in lungs of inﬂuenza virus-
infected MLK3−/− mice was similar to that in wild-type mice. This
may reﬂect either (i) in vivo production of RANTES from non-
epithelial cell types, such as T cells and/or (ii) differences related to
the virus strain used (H3N2 versus H1N1) and/or (iii) the ability of
CEP1347 to inhibit not only MLK3, but also other related family
members which may be expressed in bronchial epithelial cells
(Maroney et al., 2001).
Our in vivo studies revealed a potential role for MLK3 in viral
production during infection with inﬂuenza. We observed that virus
titers in the lung of MLK3−/−mice were increased in comparison to
230 E.A. Desmet et al. / Virology 400 (2010) 224–232wild-type mice at late time points following infection. In accordance
with our in vitro data, the increased level of virus production could be
a result of increased virus shedding from surviving infected target
cells. Enhanced survival of cells lacking MLK3 has been seen
previously in other disease models (Hong and Kim, 2007; Kim et al.,
2004; Sui et al., 2006; Zhao et al., 2007).
Overall, our work clariﬁes the role of MLK3 during inﬂuenza
infection and reveals that the loss of MLK3 is associated with
increased virus titers in the lung at late time points following
experimental infection with inﬂuenza virus. Finally, our data suggest
that elevated virus titers in MLK3−/− mice may be a result of
increased virus replication, as a consequence of the prolonged survival
of virus-infected MLK3−/− lung cells.
Materials and methods
Mice
MLK3−/− mice were obtained from Dr. R. Davis (Univ. of
Massachusetts Medical School, Worchester, MA). C57BL/6 wild-type
mice were purchased from Jackson Laboratory (Bar Harbor, ME). All
mice were on the C57BL/6J background and were bred and
maintained according to The University of Rochester Committee on
Animal Resources guidelines.
Virus infection in vivo
All infections were carried out in anesthetized eight to ten-week-
old mice following administration of 75 mg/kg Avertin (2,2,2-
tribomoethanol). Animals were infected intranasally with PR8
(Allan et al., 1990; Polakos et al., 2007) diluted in cold phosphate
buffered saline (PBS) such that a 30 μl volume contained 400 egg
infectious doses (EID) of inﬂuenza unless otherwise noted. Viral titers
in the lungs of infected mice were quantiﬁed in fertilized hen eggs.
Brieﬂy, lungs were harvested and homogenized in 1 ml cold PBS using
a Dunce homogenizer. Samples were centrifuged at 10,000 rpm for
3 min and supernatants were aliquot and stored at −80 °C. 100 μl of
lung homogenate was used to make 10-fold serial dilutions, and
100 μl of each dilution was used to inoculate into eggs in triplicate.
Following incubation, allantoic ﬂuid was harvested and used to
perform a hemagglutination assay with chicken red blood cells. The
viral end point titer was determined using the method of Reed and
Muench (1938).
Histology
Bronchial alveolar lavage wash was performed on each mouse by
instilling intratracheally 0.6 ml PBS three times followed by 1 ml of
10% formalin to inﬂate the lung. The trachea was tied off and the lung
was removed and placed in a 50 ml conical tube containing 10 ml 10%
formalin and incubated overnight. The following day lungs were then
transferred into 70% ethanol for an additional 24 h before ﬁnal
transfer into fresh 70% ethanol. Animal Resources, University of
Rochester, Rochester, NY had then conducted hematoxylin and eosin
staining of serial sections of lung tissues.
Organ harvest
Mice were anesthetized with avertin and exsanguinated via renal
artery at the indicated times after infection. Bronchial alveolar lavage
(BAL) samples were collected as stated in previous section. Spleen,
lung and mediastinal lymph node (MLN) were isolated. To create
single cell suspensions, spleen and MLN samples were homogenized
and ﬁltered through nylon mesh. Lungs were mechanically disrupted
using a tea strainer, ﬁltered through nylon mesh and lymphocytes
were separated using Histopaque 1083 (Sigma, St. Louis, MO). Spleenand lung samples were subjected to RBC lysis in 1× Gey's solution.
Single cell suspensions were counted by hemocytometer.
Flow cytometry
Single cell suspensions from organs were incubated in Hanks
Buffered Salt Solution (HBSS) with 1% BSA and 0.0025% sodium azide
containing 0.025 μg/ml puriﬁed rat anti-mouse CD16/CD32 (Fc
block) followed by addition of ﬂuorochrome-conjugated antibodies
or MHC class I tetramers. Fluorochrome-conjugated antibodies were
obtained from BD Biosciences, San Jose, CA or Biolegend, San Diego,
CA. MHC Class I tetramers H-2D containing nucleoprotein (NP)366–374
or polymerase acidic (PA)224–233 were kindly provided through a
collaboration with the Trudeau Institute Biochemistry Core (Saranac
Lake, NY) as well as obtained from the National Institute of Health
(NIH Tetramer Facility, Atlanta, GA). Flow cytometry was performed
by using a FACSCalibur (Becton Dickinson, Franklin Lakes, NJ) and the
data was analyzed with FlowJo software (Treestar, Ashland, OR).
ELISPOT analysis
ELISPOT assays were performed as previously described (Lazarski
et al., 2005; Richards et al., 2007; Richards et al., 2009). Brieﬂy, 96-
well ﬁlter plates (Millipore, Billerica, MA) were coated with 2 μg/ml
puriﬁed rat-anti-mouse interferon-γ (IFN-γ) or interleukin-2 (IL-2)
(BD Biosciences, San Jose, CA) in PBS, washed, and incubated in
serum-containing medium to block non-speciﬁc binding. CD4+ and
CD8+ T cells from the spleen (pooled) and mediastinal lymph node
(pooled) were puriﬁed by MACS negative selection using a cocktail of
biotin-conjugated monoclonal antibodies (Miltenyi Biotech, Auburn,
CA). Resulting puriﬁed T cells (3×105 cells/well) were co-cultured
with naïve splenocytes (5×105 cells/well) with immunodominant
peptides for CD4 and CD8 at a ﬁnal concentration of 10 μM each. CD4
peptides were NP261:274 and NP310:325 and CD8 peptides were NP366–
374 and PA224–233. Plates were incubated for 18 h at 37 °C in 5% CO2.
After incubation, plates were washed and incubated with 2 μg of
biotinylated rat-anti-mouse IFN-γ or IL-2 (BD Biosciences, San Jose,
CA) for 30 min at room temperature. Following this, plates were
washed and incubated for 30 min with alkaline phosphatase-
strepavidin (Jackson Immunoresearch, West Grove, PA; dilution of
1:1000). After a ﬁnal wash, plates were developed using Vector blue
substrate kit III (Vector Laboratories, Burlingame, CA) diluted in
100 mM Tris, pH 8.2. Plates were allowed to dry overnight before
counting. Spots were counted using Immunospot 3 software (Cellular
Technologies Limited, Shaker Heights, OH).
Serum collection and ELISA
Tail vein bleeding was performed on mice immediately prior to
sacriﬁce. Blood was allowed to clot at room temperature. Blood was
pelleted in a microcentrifuge and the serum was collected. Inﬂuenza-
speciﬁc ELISAs were performed by coating plates with puriﬁed PR8
viral proteins at 1 μg/ml (a kind gift from T. Randall, Univ. of
Rochester, Rochester, NY). Serum samples were diluted in 2-fold
serial dilutions in PBS with 10 mg/ml BSA and 0.1% Tween-20 and
were added to coated plates and incubated at 37 °C. Bound antibody
was detected using goat anti-mouse IgG (SouthernBiotech, Birming-
ham, AL). Following detection, plates were analyzed at OD450.
Quantiﬁcation of cytokines by ELISA
Lungs were harvested from infected mice at various time points
post-infection andwere homogenized in 1 ml PBS. The concentrations
of cytokines and chemokines in lung homogenates were then
quantiﬁed by conducting experiments with speciﬁc ELISA kits
(eBioscience, San Diego, CA).
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Wild-type and MLK3−/− lung epithelial cells were isolated from
the lung as previously described (Wang et al., 2007). Identity was
assessed by papanicolaou staining and cultures were typically N92%
pure. Cells were maintained in bronchial epithelial cell growth
medium (Cambrex) supplemented with 5% charcoal-stripped FBS
(Hyclone, Logan, UT) and 10 ng/ml keratinocyte growth factor
(Calbiochem) at 37 °C in 5% CO2.
Murine lung ﬁbroblasts
Wild-type and MLK3−/− lung ﬁbroblasts were prepared from
lung tissue explants as previously described (Baglole et al., 2006) and
were maintained in minimum essential media (MEM) (Gibco,
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS)
(Sigma Aldrich, St. Louis, MO) at 37 °C in 5% CO2.
Viability assays
Wild-type and MLK3−/− type II AECs were used by day 7
following isolation. MLFswere seeded at a density of 1×105 cells/well
one day prior to infection. To infect, both cell types were washed once
with PBS and virus in serum-free media was added at a multiplicity of
infection of 3 and incubated for 1 h at 37 °C. Following infection, cells
were washed three times with PBS and maintained in Dulbecco's
modiﬁed Eagles medium (DMEM) with 0.15% bovine serum albumin
(BSA). Cell viability was quantiﬁed by trypan blue exclusion. Brieﬂy,
supernatants from infected MLF were collected and centrifuged.
Adherent cells were incubated with trypsin at 37 °C followed by the
addition of an equal volume of serum-containing media. Cell culture
pellets and trypsinized monolayers were combined and incubated
with trypan blue for ﬁve minutes before live/dead counts were
performed using a hemocytometer.
Virus growth in lung ﬁbroblasts and epithelial cells
Wild-type andMLK3−/−MLF and AECs were infected as stated in
previous section. Virus titers in supernatants from infected cells were
determined using Madin Darby Canine Kidney (MDCK) cells. MDCK
cells were grown to conﬂuency in 96-well microtiter plates. Ten-fold
serial dilutions of wild-type and MLK3−/− culture supernatants,
harvested at various time points following infection, were added to
cells. Plates were incubated for 1.5 h at 37 °C before addition of DMEM
supplemented with 0.15% BSA and TPCK-treated trypsin. Plates were
then incubated for 4 days at 37 °C in 5% CO2. Cell supernatants were
used at this time to perform a hemagglutination assay with chicken
RBCs to determine 50% of tissue culture infective doses (TCID50/ml).
Statistical analysis
Statistical signiﬁcance was evaluated using the non-parametric
Mann–Whitney U test when comparing appropriate groups. A p value
of less than 0.05 was considered signiﬁcant.
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